跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Novpara S 250
Approved
STANDARD
Novpara S 250
Ratnamani Healthcare Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
451905c8b92bb55d
Company
Ratnamani Healthcare Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
451905c8b92bb55d
Drug Approval Philippines Name
Novpara S 250
Product Name
Novpara S 250
Registration Number
DRP-10350
Brand Name
Novpara S 250
Generic Name
Paracetamol
Dosage Form
Oral Suspension
Dosage Strength
250 mg/5 mL
Manufacturer
Ratnamani Healthcare Pvt. Ltd.
Importer
Medinova Pharmaceutical Inc.
Distributor
Medinova Pharmaceutical Inc.
Issuance Date
28 October 2021
Expiry Date
28 October 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
451905c8b92bb55d
Type
Standard
Back to Philippines FDA Approvals
Novpara S 250 - Philippines FDA Drug Approval Details